MCS MICRO CARRIER SYSTEMS GMBH has a total of 25 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are ANTOINE TURZI, NEURALIGHT HD LLC and CT DE RECH DU CT HOSPITALIER D.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 3 | |
#6 | Canada | 1 | |
#7 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Surface technology and coating | |
#5 | Biotechnology | |
#6 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Medical purpose containers | |
#5 | Metallic material removal | |
#6 | Special acyclic compounds | |
#7 | Steroids | |
#8 | Object sterilising | |
#9 | Preservation of human bodies | |
#10 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Schreier Hans | 14 |
#2 | Greb Wolfgang | 13 |
#3 | Diederichs Julia Eva | 6 |
#4 | Roeschenthaler Gerd-Volker | 4 |
#5 | Hengst Verena | 4 |
#6 | Shyhskov Oleg | 3 |
#7 | Berger Gerd | 3 |
#8 | Rudolph Carsten Martin | 2 |
#9 | Diedrichs Julia Eva | 2 |
#10 | Ritter Wolfgang | 2 |
Publication | Filing date | Title |
---|---|---|
DE102004032781A1 | New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors | |
WO2004030647A2 | Target-oriented formulations | |
DE10314083A1 | Product for the protection of blood vessels | |
DE10314082A1 | Biodegradable injectable implant | |
DE10255285A1 | Self-forming phospholipid gels | |
DE10245507A1 | Targeted liposomal formulation, especially for anticancer therapy, comprising palmitoyl-D-glucuronide, matrix phospholipid(s) and active agent(s), e.g. taxol | |
DE10245508A1 | Drug dosimeter Kombipackung | |
DE10245506A1 | Targeted liposomal formulation, especially for antibacterial, antimycotic or antiviral therapy, comprising palmitoyl-D-glucuronide, matrix phospholipid(s) and active agent(s), e.g. antibiotic |